Jones Financial Companies’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5,141
Closed -$522K 4790
2025
Q4
$522K Sell
5,141
-4,380
-46% -$352K ﹤0.01% 1503
2025
Q3
$510K Sell
9,521
-3,560
-27% -$178K ﹤0.01% 1391
2025
Q2
$702K Sell
13,081
-41
-0.3% -$2.08K ﹤0.01% 1154
2025
Q1
$573K Buy
13,122
+3,614
+38% +$183K ﹤0.01% 1069
2024
Q4
$534K Buy
9,508
+2,315
+32% +$144K ﹤0.01% 969
2024
Q3
$474K Buy
7,193
+3,330
+86% +$188K ﹤0.01% 839
2024
Q2
$163K Buy
3,863
+3,291
+575% +$181K ﹤0.01% 894
2024
Q1
$39.5K Buy
572
+543
+1,872% +$34.3K ﹤0.01% 773
2023
Q4
$2.15K Buy
+29
New +$1.9K ﹤0.01% 898
2021
Q2
Sell
-31
Closed -$4K 683
2021
Q1
$4K Buy
+31
New +$4.24K ﹤0.01% 648

Other funds holding EXAS

Jones Financial Companies's EXAS Position: Q1 2026 in Review

Jones Financial Companies sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 5,141 shares — an estimated $522K sold.

Jones Financial Companies first reported a position in EXAS in Q1 2021 and held it in 10 quarters. The position peaked at $702K in Q2 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Jones Financial Companies reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Jones Financial Companies sold 5,141 Exact Sciences shares in Q1 2026, an estimated $522K.
  • Jones Financial Companies first reported a position in Exact Sciences in Q1 2021 and held it in 10 quarters.
  • Jones Financial Companies's Exact Sciences position peaked at $702K in Q2 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.